Education
About Us
Working with TipRanks
Follow Us
John Patience Insider Profile
4 Followers
John Patience, Director at Stericycle, holds 7.44M shares in Biodesix (Ticker: BDSX), holds 871.21K shares in Accelerate Diagnostics (Ticker: AXDXQ), holds 151.11K shares in Stericycle (Ticker: SRCL).
Profitable Transactions
10 out of 22 Profitable Transactions
Average Return
-20.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Patience holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 09, 2016 - Feb 09, 2017
Return:+108.20%
The most profitable trade made by John Patience
John Patience's Trading History
Stericycle
May 24, 2018
―
Uninformative Buy
417.92K
$9.37M
Accelerate Diagnostics
Dec 03, 2024
Director
Informative Buy
314.00K
$8.71K
Biodesix
Jul 02, 2025
Director, Chairman
Uninformative Buy
6.45K
$2.37M
List of latest transactions for each holding click on a transaction to see John Patience's performance on stock
You May Also Like
John Patience insider profile FAQ
What is the percentage of profitable transactions made by John Patience?
The percentage of profitable transactions made by John Patience is 45%.
What is the average return per transaction made by John Patience?
The average return per transaction made by John Patience is -20.30%.
What stocks does John Patience hold?
John Patience holds: SRCL, AXDXQ, BDSX stocks.
What was John Patience’s latest transaction?
John Patience latest transaction was an Uninformative Buy of $6.45K.
What was John Patience's most profitable transaction?
John Patience’s most profitable transaction was an Informative Buy of AXDXQ stock on February 9, 2016. The return on the trade was 108.20%.
What is John Patience's role in Stericycle?
John Patience's role in Stericycle is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.